U.S. markets closed

Antares Pharma, Inc. (ATRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.0600+0.0200 (+0.50%)
At close: 4:00PM EDT

4.0600 0.00 (0.00%)
After hours: 5:49PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/12/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
689.46M665.68M450.01M456.73M390.72M
Enterprise Value 3
683.24M659.22M445.32M453.45M392.09M
Trailing P/E
12.4266.5069.40275.00N/A
Forward P/E 1
15.7514.779.64N/A23.58
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
4.664.693.233.373.86
Price/Book (mrq)
5.7910.207.858.497.17
Enterprise Value/Revenue 3
4.5714.9411.1314.0011.85
Enterprise Value/EBITDA 7
41.8394.4469.84122.42-540.81

Trading Information

Stock Price History

Beta (5Y Monthly) 1.48
52-Week Change 352.45%
S&P500 52-Week Change 348.80%
52 Week High 35.0700
52 Week Low 32.3900
50-Day Moving Average 34.2063
200-Day Moving Average 33.7682

Share Statistics

Avg Vol (3 month) 31.26M
Avg Vol (10 day) 3581.26k
Shares Outstanding 5168.16M
Implied Shares Outstanding 6N/A
Float 155.95M
% Held by Insiders 17.47%
% Held by Institutions 145.65%
Shares Short (Mar 30, 2021) 44.89M
Short Ratio (Mar 30, 2021) 43.6
Short % of Float (Mar 30, 2021) 42.96%
Short % of Shares Outstanding (Mar 30, 2021) 42.91%
Shares Short (prior month Feb 25, 2021) 44.1M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Jan 28, 1999

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 37.57%
Operating Margin (ttm)9.10%

Management Effectiveness

Return on Assets (ttm)4.93%
Return on Equity (ttm)64.74%

Income Statement

Revenue (ttm)149.6M
Revenue Per Share (ttm)0.90
Quarterly Revenue Growth (yoy)16.60%
Gross Profit (ttm)86.5M
EBITDA 16.25M
Net Income Avi to Common (ttm)56.2M
Diluted EPS (ttm)0.3300
Quarterly Earnings Growth (yoy)994.50%

Balance Sheet

Total Cash (mrq)53.14M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)46.92M
Total Debt/Equity (mrq)39.39
Current Ratio (mrq)2.00
Book Value Per Share (mrq)0.71

Cash Flow Statement

Operating Cash Flow (ttm)21.32M
Levered Free Cash Flow (ttm)5.98M